BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

미국 National Institutes of Health의 보조금/지원금 프로그램입니다. 지원 규모는 확인이 필요합니다. 접수 마감은 2026.09.28입니다. 현재 상태는 "모집중"입니다. 자부담과 지분 요구가 없습니다. The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating de…

The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain (e.g., Early Feasibility Study). Clinical studies supported may consist of acute or short-term procedures that are deemed Non-Significant Risk (NSR) by an Institutional Review Board (IRB), or Significant Risk (SR) studies that require an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical trial should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical trial is expected to provide information that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Activities supported by this Funding Opportunity include a small clinical trial to answer key questions about the function or final design of a device.As part of the BRAIN Initiative, NIH has initiated a Public-Private Partnership Program (BRAIN PPP) that includes agreements (Memoranda of Understanding, MOU) with a number of device manufacturers willing to make such devices available, including devices and capabilities not yet market approved but appropriate for clinical research. In general it is expected that the devices' existing safety and utility data will be sufficient to enable new IRB NSR or FDA IDE approval without need for significant additional non-clinical data. For more information on the BRAIN PPP, see http://braininitiative.nih.gov/BRAIN_PPP/index.htm

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

주 대상 국가

🇺🇸 미국

추가 적격 국가

없음

해외기업 지원

불가

현지 법인

필수

지역 조건

미국 연방 지원사업으로 미국 내 적격 신청주체가 필요합니다.

제출서류 정보가 수집되지 않았습니다 (확인 필요). 공식 공고문에서 직접 확인하세요.

신청 절차 정보가 확인되지 않았습니다.

평가 절차 정보가 확인되지 않았습니다.

신청 절차 정보가 확인되지 않았습니다.

• Bayh-Dole 정부 실시권

  미국 연방 R&D 자금 특성상 정부 실시권 조항이 적용될 수 있습니다.

  근거: grants.gov 연방 지원사업 공통 조항 — 개별 공고 확인 필요

생성: local:rules-v1 · 3시간 전

제한적 공개를 권장합니다. 요구 자료 범위가 확인되지 않았습니다(노출 점수 45/100). 운영주체는 National Institutes of Health입니다. 미확인 항목 7건은 공고문·협약서에서 직접 확인이 필요합니다.

이 분석은 저장된 공고·서류·계약 조건 필드에 근거합니다. 근거가 없는 항목은 “확인 필요”로 표시되며, 아이디어 탈취 여부를 단정하지 않습니다. 생성: local:rules-v1 · 3시간 전

공식 URL

https://www.grants.gov/search-results-detail/356982

신청 URL

https://www.grants.gov/search-results-detail/356982

Last Verified

2026.08.11

최초 수집

2026.08.11

데이터 상태

AI 파싱

AI 보강

local:rules-v1 · 3시간 전